The primary goal of the MNORC Pilot and Feasibility Grants Program (P/F) is to promote research on the biological and behavioral determinants of obesity, and to develop interventions to reduce obesity and its disease sequelae using basic, clinical, or population approaches. To achieve this goal, we provide opportunities for both new and established University of Michigan investigators to generate sufficient preliminary information for a successful application for major research funding from NIH or other national granting agencies. The ~$100 K/year for the MNORC P/F grants problem is largely funded from cost-sharing provided by several Schools within the University of Michigan, and is currently in the midst of its fifth cycle of funding. Two to three standard grants have been given out each year, and despite the program still being in its infancy, this investment has resulted in a considerable return of published papers, funded NIH grants, and collaborations with other MNORC members. The MNORC has also initiated a series of novel and popular ?Small Grants? of $5,000-$10,000, with equal contributions from MNORC and the Michigan Institute for Clinical and Health Research (MICHR) for access to Core services. In addition to the traditional and small grant currently provided, the P/F program will expand over the next cycle to include shared grants funded with MICHR for study of humans or involving human samples, with the Michigan Diabetes Research Center for common research interests using metabolomic, proteomic or transcriptomic approaches and with the Digestive Diseases Research Center to study the relationships between the microbiome and nutrition and obesity. Finally, the MNORC will provide up to $15,000 for investigators to access the new Epigenomics Core, which is co-supported by the U-M Medical School and MNORC.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK089503-09
Application #
9514136
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
9
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Sepehrband, Farshid; Lynch, Kirsten M; Cabeen, Ryan P et al. (2018) Neuroanatomical morphometric characterization of sex differences in youth using statistical learning. Neuroimage 172:217-227
Jiang, Lin; Su, Haoran; Keogh, Julia M et al. (2018) Neural deletion of Sh2b1 results in brain growth retardation and reactive aggression. FASEB J 32:1830-1840
Bagchi, Devika P; Forss, Isabel; Mandrup, Susanne et al. (2018) SnapShot: Niche Determines Adipocyte Character I. Cell Metab 27:264-264.e1
Perng, Wei; Tang, Lu; Song, Peter X K et al. (2018) Metabolomic profiles and development of metabolic risk during the pubertal transition: a prospective study in the ELEMENT Project. Pediatr Res :
Peck, Bailey C E; Seeley, Randy J (2018) How does 'metabolic surgery' work its magic? New evidence for gut microbiota. Curr Opin Endocrinol Diabetes Obes 25:81-86
Horowitz, Jeffrey F; Ortega, Juan F; Hinko, Alexander et al. (2018) Changes in markers for cardio-metabolic disease risk after only 1-2 weeks of a high saturated fat diet in overweight adults. PLoS One 13:e0198372
Meng, Zhuo-Xian; Tao, Weiwei; Sun, Jingxia et al. (2018) Uncoupling Exercise Bioenergetics From Systemic Metabolic Homeostasis by Conditional Inactivation of Baf60 in Skeletal Muscle. Diabetes 67:85-97
Isaman, Deanna J M; Rothberg, Amy E; Herman, William H (2018) The Effect of Attrition on Reported Diabetes Remission Rates Following Roux-en-Y Gastric Bypass: a Sensitivity Analysis. Obes Surg 28:1308-1312
Tang, Ming; Gao, Chao; Goutman, Stephen A et al. (2018) Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering. Neuroinformatics :
Ward, Kristen M; Yeoman, Larisa; McHugh, Cora et al. (2018) Atypical Antipsychotic Exposure May Not Differentiate Metabolic Phenotypes of Patients with Schizophrenia. Pharmacotherapy 38:638-650

Showing the most recent 10 out of 342 publications